Abbott Laboratories (ABT)vsCytosorbents Crp (CTSO)
ABT
Abbott Laboratories
$95.39
+3.49%
HEALTHCARE · Cap: $163.94B
CTSO
Cytosorbents Crp
$0.39
-5.94%
HEALTHCARE · Cap: $22.75M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 121228% more annual revenue ($45.13B vs $37.20M). ABT leads profitability with a 13.9% profit margin vs -31.9%. ABT earns a higher WallStSmart Score of 54/100 (C-).
ABT
Buy54
out of 100
Grade: C-
CTSO
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-32.7%
Fair Value
$70.91
Current Price
$95.39
$24.48 premium
Intrinsic value data unavailable for CTSO.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
No standout strengths identified
Areas to Watch
Moderate valuation
Earnings declined 19.7%
Trading at 9.8x book value
1.6% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. PEG of 1.40 suggests the stock is reasonably priced for its growth.
Bull Case : CTSO
CTSO has a balanced fundamental profile.
Bear Case : ABT
The primary concerns for ABT are P/E Ratio, EPS Growth.
Bear Case : CTSO
The primary concerns for CTSO are Price/Book, Revenue Growth, EPS Growth. Debt-to-equity of 8.64 is elevated, increasing financial risk.
Key Dynamics to Monitor
ABT profiles as a value stock while CTSO is a turnaround play — different risk/reward profiles.
CTSO carries more volatility with a beta of 1.36 — expect wider price swings.
ABT is growing revenue faster at 7.8% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
ABT scores higher overall (54/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Cytosorbents Crp
HEALTHCARE · MEDICAL DEVICES · USA
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?